Singular Genomics Systems, Inc., was incorporated in Delaware in June 2016 and its principal operations are in La Jolla, California. Their mission is to accelerate the development of genomics for the advancement of science and medicine. Since the first sequencing of the human genome, genomic tools and technologies developed over the past two decades have greatly improved their understanding of biology, fueling the development of novel therapies and advanced clinical diagnosis. They are a life science technology company that is leveraging novel NGS and multiomics technologies to develop products that empower researchers and clinicians. They developed a unique and proprietary NGS technology called a sequencing engine. The sequencing engine is the underlying platform technology that forms the basis of its product development and its core product tenets: accuracy, speed, flexibility and scale. 

OMIC(Delisted)

OMIC(Delisted)